133 related articles for article (PubMed ID: 38720305)
1. Real-world efficacy of adjuvant therapy for totally resected stage I lung adenocarcinoma patients with pathological high-risk factors: propensity score analysis.
Zhao K; Yang L; Liu L; Wang G; Zhang J; Gao X; Guo C; Huang C; Chen Y; Li S
BMC Surg; 2024 May; 24(1):140. PubMed ID: 38720305
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of adjuvant chemotherapy for lung adenocarcinoma patients with positive pleural lavage cytology findings.
Ogawa H; Uchino K; Tanaka Y; Shimizu N; Okuda Y; Tane K; Tauchi S; Nishio W; Maniwa Y; Yoshimura M
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):34-9. PubMed ID: 25911680
[TBL] [Abstract][Full Text] [Related]
4. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
[TBL] [Abstract][Full Text] [Related]
6. Impact of Nodule Density in Women With Sublobar Resection for Stage IA Adenocarcinoma.
Phillips WW; Gill RR; Mazzola E; Armitage JR; de Forcrand C; Colson YL; Gibney BC
Ann Thorac Surg; 2021 Oct; 112(4):1067-1075. PubMed ID: 33181131
[TBL] [Abstract][Full Text] [Related]
7. Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection.
Jiang MQ; Qian LQ; Shen YJ; Fu YY; Feng W; Ding ZP; Han YC; Fu XL
Neoplasia; 2024 Apr; 50():100979. PubMed ID: 38387107
[TBL] [Abstract][Full Text] [Related]
8. Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients.
Li X; Zhang C; Sun Z; Yang F; Xiao R; Sui X; Jiang G; Zhong W; Wang J
Lung Cancer; 2019 Jul; 133():75-82. PubMed ID: 31200832
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung Adenocarcinoma.
Yang L; Zhang J; Yang G; Xu H; Lin J; Shao L; Li J; Guo C; Du Y; Guo L; Li X; Han-Zhang H; Wang C; Chuai S; Ye J; Kang Q; Liu H; Ying J; Wang Y
Theranostics; 2020; 10(17):7635-7644. PubMed ID: 32685009
[TBL] [Abstract][Full Text] [Related]
10. Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial.
Su S; Scott WJ; Allen MS; Darling GE; Decker PA; McKenna RJ; Meyers BF
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):747-52: Discussion 752-3. PubMed ID: 24290575
[TBL] [Abstract][Full Text] [Related]
11. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity-matched analysis in a cohort of 147 recurrences.
Xu F; Chen HC; Xu H; Li J; Hao X; Xing P; Ying J; Wang Y
Thorac Cancer; 2022 Nov; 13(22):3105-3113. PubMed ID: 36104006
[TBL] [Abstract][Full Text] [Related]
13. Survival Prediction and Adjuvant Chemotherapy Based on Tumor Marker for Stage IB Lung Adenocarcinoma.
Wang Y; Zheng D; Chen T; Zhang J; Yao F; Chen H
Ann Thorac Surg; 2020 Mar; 109(3):927-937. PubMed ID: 31614135
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.
Li R; Qiu J; Li Z; Li H; Tang Z; Yu W; Tian H; Sun Z
World J Surg Oncol; 2024 Jan; 22(1):32. PubMed ID: 38273367
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
Wang S; Xu J; Wang R; Qian F; Yang W; Qiao R; Zhang B; Qian J; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Nov; 156(5):2006-2015.e2. PubMed ID: 30104070
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of multiple high-risk histopathological criteria improves the prediction of adjuvant chemotherapy efficacy in lung adenocarcinoma.
Sereno M; He Z; Smith CR; Baena J; Das M; Hastings RK; Rake G; Fennell DA; Nakas A; Moore DA; Le Quesne J
Histopathology; 2021 May; 78(6):838-848. PubMed ID: 33155719
[TBL] [Abstract][Full Text] [Related]
17. [Outcomes and the role of adjuvant therapy of limited stage small cell lung cancer undergoing surgical treatment].
Yu J; Ouyang W; Huang Z; Chen G; Zhou Y; Mao YL; Zhang JH; Xie CH
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):336-339. PubMed ID: 32375451
[No Abstract] [Full Text] [Related]
18. Significance of Lymphadenectomy in Part-Solid Lung Adenocarcinoma: Propensity Score Matched Analysis.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Ann Thorac Surg; 2018 Oct; 106(4):989-997. PubMed ID: 29852148
[TBL] [Abstract][Full Text] [Related]
19. Propensity-Matched Analysis Comparing Survival After Sublobar Resection and Lobectomy for cT1N0 Lung Adenocarcinoma.
Chiang XH; Hsu HH; Hsieh MS; Chang CH; Tsai TM; Liao HC; Tsou KC; Lin MW; Chen JS
Ann Surg Oncol; 2020 Mar; 27(3):703-715. PubMed ID: 31646453
[TBL] [Abstract][Full Text] [Related]
20. Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma.
Sasada S; Miyata Y; Mimae T; Tsutani Y; Mimura T; Okada M
Clin Lung Cancer; 2016 Sep; 17(5):433-440.e1. PubMed ID: 26725850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
